Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variants
- 1 January 2005
- journal article
- review article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 43 (9) , 897-902
Abstract
High plasma levels of triglycerides are an independent risk factor for the development of cardiovascular disease. Apolipoprotein A5 (It has now been clearly established that distinct polymorphisms in theThe possible roles ofKeywords
This publication has 42 references indexed in Scilit:
- Hypertriglyceridemia: Interaction between APOE and APOAV VariantsClinical Chemistry, 2005
- APOA5 polymorphisms influence plasma triglycerides in young, healthy African Americans and whites of the CARDIA StudyJournal of Lipid Research, 2005
- Hyperlipidemia in Patients with Apolipoprotein E 2/2 Phenotype: Apolipoprotein A5 S19W Mutation as a CofactorClinical Chemistry, 2004
- APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery diseaseAtherosclerosis, 2004
- Association of the APOLIPOPROTEIN A1/C3/A4/A5 Gene Cluster With Triglyceride Levels and LDL Particle Size in Familial Combined HyperlipidemiaCirculation Research, 2004
- Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildrenHuman Genetics, 2002
- A comprehensive linkage analysis for myocardial infarction and its related risk factorsNature Genetics, 2002
- Positional cloning of the combined hyperlipidemia gene Hyplip1Nature Genetics, 2001
- Triglycerides: risk factor or fellow traveler?Current Opinion in Cardiology, 2001
- Hepatic lipaseCurrent Opinion in Lipidology, 1999